grant

Mechanisms by which ICP3 Overcomes Vibrio cholerae Phage Defenses

Organization TUFTS UNIVERSITY BOSTONLocation BOSTON, UNITED STATESPosted 1 Jul 2024Deadline 28 Feb 2027
NIHUS FederalResearch GrantFY2025AntigensBacteriaBacterial InfectionsBacteriophagesBioinformaticsBionomicsCTXCYCLO-cellCarloxanCausalityCholeraCholera Enterotoxin CTCholera ExotoxinCholera ToxinCholeragenCiclofosfamidaCiclofosfamideCicloxalClafenClapheneClassificationClinicalComplementComplement ProteinsCycloblastinCycloblastineCyclophosphamCyclophosphamideCyclophosphamidumCyclophosphanCyclophosphaneCyclophosphanumCyclostinCyclostineCytophosphanCytophosphaneCytoxanDNA Restriction-Modification EnzymesDataDefense MechanismsDevelopmentDiarrheaEcologyEndoxanEndoxanaEnduxanEnvironmentEtiologyEvolutionFosfaseronFunding MechanismsFutureGene DeletionGenesGeneticGenomeGenoxalGenuxalHost DefenseHost resistanceHumanInfectionIntestinalIntestinesLedoxinaLibrariesLife CycleLife Cycle StagesMeasuresMitoxanModelingModern ManMulti-Drug ResistanceMultidrug ResistanceMultiple Drug ResistanceMultiple Drug ResistantNeosarORFsOpen Reading FramesPathogenicity FactorsPatientsPhagesPlayPopulationPredatory BehaviorPreventionProcytoxProphylactic treatmentProphylaxisProtein Coding RegionProteinsReceptor ProteinReportingResistanceResistance to Multi-drugResistance to MultidrugResistance to Multiple DrugResistant to Multiple DrugResistant to multi-drugResistant to multidrugRestriction-Modification SystemsRoleSendoxanSmall IntestinesSpecificityStructural ModelsSuppressor MutationsSyklofosfamidSystemSystematicsTestingTn-seqTnseqV choleraeV cholerae O1V cholerae Serogroup O1V. choleraeV. cholerae O1V. cholerae Serogroup O1ValidationVibrio choleraeVibrio cholerae O1Vibrio cholerae Serogroup O1Vibrio commaVirulenceVirulence FactorsVirulentVirusWorkZytoxanarms racebacteria infectionbacteria pathogenbacterial diseasebacterial pathogenbacterial virusbowelcausationcomplementationcostdeletion collectiondeletion librarydensitydevelopmentaldisease causationentire genomefitnessfull genomegene deletion mutationgenetic analysisgenome sequencingimmunogeninsightinterestlife courselytic replicationlytic viral replicationlytic virus replicationmulti-drug resistantmultidrug resistantmutantpathogenpathogenic bacteriapredationpreventpreventingprotein functionpsychological defense mechanismreceptorresistance mechanismresistantresistant mechanismsmall bowelsocial roletransposon insertion sequencingtransposon sequencingvalidationswhole genome
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Bacteriophages (phages) are bacteria-specific viruses. Phages play a major role in the life cycle and evolution

of Vibrio cholerae, the bacteria that causes cholera. Despite the presence of many V. cholerae-specific phage

types in the environment, only three types, ICP1, ICP2 and ICP3, are commonly found at high concentrations

in the watery diarrhea shed by cholera patients. Thus, these three phages are special for their ability to survive

in the human intestinal tract, where they replicate on and kill V. cholerae. Of these phages, ICP3 is the most

virulent in terms of its ability to kill V. cholerae. The emergence of resistance to ICP1, ICP2 and to other phages

is frequent in V. cholerae, but, for unknown reasons, resistance to ICP3 is exceedingly rare. This makes ICP3

of great interest for use as a product to treat or prevent cholera. The use of phages for therapy or prevention of

bacterial infections is gaining broad interest due to the emergence of multidrug resistance in many bacterial

pathogens, including V. cholerae. To gain a better understanding of ICP3’s virulence and lack of emergence of

host resistance, in this exploratory project we will delete each of the approximately four dozen accessory genes

of ICP3 and test their roles in circumventing the phage defense systems of V. cholerae. Addionally, we will

identify the cognate host phage defense genes in V. cholerae for each ICP3 accessory gene. The results will

shed much light on ICP3's special abilities, and will encourage the development of ICP3 into a product for use

in combatting cholera.

Grant Number: 5R21AI181039-02
NIH Institute/Center: NIH

Principal Investigator: Andrew Camilli

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →